Open Access

[Corrigendum] Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer

  • Authors:
    • Lizhe Zhu
    • Nan Ma
    • Bin Wang
    • Can Zhou
    • Yu Yan
    • Ke Wang
    • Jianjun He
    • Yu Ren
  • View Affiliations

  • Published online on: February 23, 2021     https://doi.org/10.3892/ol.2021.12572
  • Article Number: 311
  • Copyright : © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Lett 17: [Related article:] 5469-5480, 2019; DOI: 10.3892/ol.2019.10277

Following the publication of the above paper, which was entitled ‘Clinical analysis of 21-gene recurrence score test in hormone receptor-positive early-stage breast cancer’, it was drawn to the Editor's attention that the use of “Recurrence Score”, as featured in the title and in the main text of the paper, was an infringement of registered trademarks held by Genomic Health, Inc. with its Oncotype DX test. It should also be noted that Genomic Health, Inc. were involved neither in the preparation of the article nor in the underlying testing with its Oncotype DX test.

A suggestion was made that the term ‘recurrence score’ could have been written as ‘relapse score’ without losing the intended meaning and without infringing upon the trademark. Therefore, the titled has been rephrased to ‘Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer’, as shown above; furthermore, ‘recurrence score’ should have been written as ‘relapse score’ at the start of the abstract on p. 5469, in the second sentence of the second paragraph of the Introduction (p. 5469), and in the titles and/or legends of Tables I–VII and Figs. 1–4.

Related Articles

Journal Cover

April-2021
Volume 21 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu L, Ma N, Wang B, Zhou C, Yan Y, Wang K, He J and Ren Y: [Corrigendum] Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer. Oncol Lett 21: 311, 2021.
APA
Zhu, L., Ma, N., Wang, B., Zhou, C., Yan, Y., Wang, K. ... Ren, Y. (2021). [Corrigendum] Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer. Oncology Letters, 21, 311. https://doi.org/10.3892/ol.2021.12572
MLA
Zhu, L., Ma, N., Wang, B., Zhou, C., Yan, Y., Wang, K., He, J., Ren, Y."[Corrigendum] Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer". Oncology Letters 21.4 (2021): 311.
Chicago
Zhu, L., Ma, N., Wang, B., Zhou, C., Yan, Y., Wang, K., He, J., Ren, Y."[Corrigendum] Clinical analysis of 21-gene relapse score test in hormone receptor-positive early-stage breast cancer". Oncology Letters 21, no. 4 (2021): 311. https://doi.org/10.3892/ol.2021.12572